These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7498115)

  • 21. Use of hormone replacement therapy after risk-reducing salpingo-oophorectomy.
    Johansen N; Liavaag AH; Iversen OE; Dørum A; Braaten T; Michelsen TM
    Acta Obstet Gynecol Scand; 2017 May; 96(5):547-555. PubMed ID: 28236297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy with climara in surgical menopause.
    Bădoi D; Crauciuc E; Rusu L; Luca V
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):828-33. PubMed ID: 23272537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation.
    Hall E; Finch A; Jacobson M; Rosen B; Metcalfe K; Sun P; Narod SA; Kotsopoulos J
    Gynecol Oncol; 2019 Jan; 152(1):145-150. PubMed ID: 30414741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone replacement therapy and lipid-lipoprotein concentrations.
    Gökmen O; Yapar Eyi EG
    Eur J Obstet Gynecol Reprod Biol; 1999 Jul; 85(1):31-41. PubMed ID: 10428319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of non-oral estrogen on risk markers for metabolic syndrome in early surgically menopausal women.
    Kilic S; Yilmaz N; Erdogan G; Aydin M; Tasdemir N; Doganay M; Batioglu S
    Climacteric; 2010 Feb; 13(1):55-62. PubMed ID: 19591007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Women awaiting hysterectomy: a qualitative study of issues involved in decisions about oophorectomy.
    Bhavnani V; Clarke A
    BJOG; 2003 Feb; 110(2):168-74. PubMed ID: 12618161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychosexual health 5 years after hysterectomy: population-based comparison with endometrial ablation for dysfunctional uterine bleeding.
    McPherson K; Herbert A; Judge A; Clarke A; Bridgman S; Maresh M; Overton C
    Health Expect; 2005 Sep; 8(3):234-43. PubMed ID: 16098153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Affective symptoms in women attending a menopause clinic.
    Hay AG; Bancroft J; Johnstone EC
    Br J Psychiatry; 1994 Apr; 164(4):513-6. PubMed ID: 8038941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormonal therapy in the patient with surgical menopause.
    Weinstein L
    Obstet Gynecol; 1990 Apr; 75(4 Suppl):47S-50S; discussion 51S-52S. PubMed ID: 2179790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term health consequences of premature or early menopause and considerations for management.
    Faubion SS; Kuhle CL; Shuster LT; Rocca WA
    Climacteric; 2015; 18(4):483-91. PubMed ID: 25845383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of conjugated estrogens with and without medrogestone: a prospective study.
    van der Mooren MJ; Leuven JA; Rolland R
    Maturitas; 1994 May; 19(1):33-42. PubMed ID: 7935030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormones and menopausal status as predictors of depression in women in transition to menopause.
    Freeman EW; Sammel MD; Liu L; Gracia CR; Nelson DB; Hollander L
    Arch Gen Psychiatry; 2004 Jan; 61(1):62-70. PubMed ID: 14706945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Attitude and sex behavior following hysterectomy].
    Seidenschnur G; Beck H; Uplegger H; Werner H; Kolmorgen K
    Zentralbl Gynakol; 1989; 111(1):53-9. PubMed ID: 2922978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychological effects of continuation versus discontinuation of hormone replacement therapy by estrogen implants: a placebo-controlled study.
    Pearce J; Hawton K; Blake F; Barlow D; Rees M; Fagg J; Keenan J
    J Psychosom Res; 1997 Feb; 42(2):177-86. PubMed ID: 9076645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compliance with estrogen hormone replacement therapy after oophorectomy: a prospective study.
    Read MD; Edey KA; Hapeshi J; Foy C
    Menopause Int; 2010 Jun; 16(2):60-4. PubMed ID: 20729495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential adverse effects of prophylactic bilateral salpingo-oophorectomy on skin aging in premenopausal women undergoing hysterectomy for benign conditions.
    Töz E; Özcan A; Balsak D; Avc ME; Eraslan AG; Balc DD
    Menopause; 2016 Feb; 23(2):138-42. PubMed ID: 26382316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mood symptoms after natural menopause and hysterectomy with and without bilateral oophorectomy among women in midlife.
    Gibson CJ; Joffe H; Bromberger JT; Thurston RC; Lewis TT; Khalil N; Matthews KA
    Obstet Gynecol; 2012 May; 119(5):935-41. PubMed ID: 22525904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of risk-reducing salpingo-oophorectomy in premenopausal women.
    Vermeulen RFM; Beurden MV; Korse CM; Kenter GG
    Climacteric; 2017 Jun; 20(3):212-221. PubMed ID: 28509627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic oophorectomy at elective hysterectomy. Effects on psychological well-being at 1-year follow-up and its correlations to sexuality.
    Aziz A; Bergquist C; Nordholm L; Möller A; Silfverstolpe G
    Maturitas; 2005 Aug; 51(4):349-57. PubMed ID: 16039407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A natural experiment on the effects of ovarian hormones on cardiovascular risk factors and stress reactivity: bilateral salpingo oophorectomy versus hysterectomy only.
    Stoney CM; Owens JF; Guzick DS; Matthews KA
    Health Psychol; 1997 Jul; 16(4):349-58. PubMed ID: 9237087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.